FPS
CLLS

Fieldpoint Private Securities’s Cellectis CLLS Stock Holding History

Fieldpoint Private Securities’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-55
Closed -$1K – 1652
2021
Q2 		$1K Sell
55
-60
-52% -$1.01K ﹤0.01% 1451
2021
Q1 		$2K Hold
115
– – ﹤0.01% 1363
2020
Q4 		$3K Buy
+115
New +$2.58K ﹤0.01% 1226

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

Fieldpoint Private Securities's CLLS Position: Q3 2021 in Review

Fieldpoint Private Securities sold out of Cellectis (CLLS) in Q3 2021, closing a stake of 55 shares — an estimated $1K sold.

Fieldpoint Private Securities first reported a position in CLLS in Q4 2020 and held it in 3 quarters. The position peaked at $3K in Q4 2020. 70 funds tracked by Wall St. Rank hold CLLS as of Q3 2021.

  • Fieldpoint Private Securities reported no remaining Cellectis position as of Q3 2021 after selling out during the quarter.
  • Fieldpoint Private Securities sold 55 Cellectis shares in Q3 2021, an estimated $1K.
  • Fieldpoint Private Securities first reported a position in Cellectis in Q4 2020 and held it in 3 quarters.
  • Fieldpoint Private Securities's Cellectis position peaked at $3K in Q4 2020.
  • 70 funds tracked by Wall St. Rank held Cellectis as of Q3 2021.

Based on Fieldpoint Private Securities's 13F filing for Q3 2021, filed 12 Nov 2021.